Need help?

EN ISO 18562-1:2024 Standard

wave
Save  

  Keywords:

#medical #use #device #respiratory #biological

  Directive

Medical devices Regulation ((EU) 2017/745)

  Last Official Journal reference

Wednesday 1st of April 2026

  Description:

Biocompatibility evaluation of breathing gas pathways in healthcare applications - Part 1: Evaluation and testing within a risk management process (ISO 18562-1:2024)

  Purpose

ISO 18562-1 specifies: —  the general principles governing the biological evaluation within a risk management process of the gas pathways of a medical device, its parts or accessories, which are intended to provide respiratory care or supply substances via the respiratory tract to a patient in all environments, — the general categorization of gas pathways based on the nature and duration of their contact with the gas stream, — the evaluation of existing relevant data from all sources, — the identification of gaps in the available data set based on a risk analysis, — the identification of additional data sets necessary to analyse the biological safety of the gas pathway, — the assessment of the biological safety of the gas pathway. ISO 18562-1 covers general principles regarding biocompatibility assessment of medical device materials, which make up the gas pathway, in normal use and normal conditions. This document does not cover biological hazards arising from mechanical damage. The other parts of ISO 18562 cover specific tests that address potentially hazardous substances that are added to the respirable gas stream and establish acceptance criteria for these substances. It addresses potential contamination of the gas stream arising from the gas pathways within the medical device, which might then be conducted to the patient. This standard applies over the expected lifetime of the medical device when operated according to the instructions for use. This includes degradation arising from exposure to environmental conditions as well as cleaning, disinfection and sterilisation (i.e. processing). It also includes user action or inaction (omission) that leads to an unintended or unexpected outcome (result) (i.e. use error). It does not include conscious/intentional action or inaction that violates the instructions for use and is beyond reasonable risk control by the manufacturer (i.e. abnormal use). Medical devices, parts or accessories containing gas pathways that are addressed by this document include, but are not limited to, ventilators, anesthesia workstations (including gas mixers), breathing systems, oxygen-conserving equipment, oxygen concentrators, nebulizers, low-pressure hose assemblies, humidifiers, heat and moisture exchangers, respiratory gas monitors, respiration monitors, masks, medical respiratory personal protective equipment, mouthpieces, resuscitators, breathing tubes, breathing system filters and Y-pieces as well as any breathing accessories intended to be used with such medical devices. The enclosed chamber of an incubator, including the mattress, and the inner surface of an oxygen hood are considered to be gas pathways and are also addressed by this document. ISO 18562-1:2024 text has been approved in Europe as EN ISO 18562-1:2024 without any changes.

  Publication

Wednesday 28th of January 2026

  Related Standards

EN IEC 60118-0:2024

Medical devices Regulation ((EU) 2017/745)

Electroacoustics - Hearing aids - Part 0: Measurement of the performance characteristics of hearing aids

EN ISO 11607-2:2020/A1:2023

Medical devices Regulation ((EU) 2017/745)

Packaging for terminally sterilized medical devices - Part 2: Validation requirements for forming, sealing and assembly processes ...

EN 455-3:2023

Medical devices Regulation ((EU) 2017/745)

Medical gloves for single use - Part 3: Requirements and testing for biological evaluation

EN ISO 10993-15:2023

Medical devices Regulation ((EU) 2017/745)

Biological evaluation of medical devices - Part 15: Identification and quantification of degradation products from metals and allo...

EN ISO 10993-17:2023

Medical devices Regulation ((EU) 2017/745)

Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO 10993-17:202...

EN ISO 10993-18:2020

Medical devices Regulation ((EU) 2017/745)

Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management...

  Stay up to date

  ACCESS

Search for a standard
GO

Register

Already a member?
Login

  OTHER APPLICATIONS

If you are interested in DO160 tests, you can give a try to our other free of charge software:
CE-Marking assistant, Version: 1.3.0